Placebo News and Research

RSS

What are the frequency and risk of adverse events developing in patients with epilepsy who are using CBD?

Researchers evaluated epilepsy patients to evaluate cannabidiol use-related adverse events.

24 Apr 2023

An exploration of the pathophysiological factors and abnormalities of coagulation of long-COVID

Researchers explored the pathophysiological variables and coagulation abnormalities associated with long coronavirus disease (COVID).

21 Apr 2023

Review confirms that cranberry products help prevent urinary tract infections

Review reports that cranberry products containing proanthocyanidins (PACs) can reduce the risk of symptomatic, culture-verified UTIs in women with recurrent UTIs, in children, and in people susceptible to UTIs following interventions.

21 Apr 2023

Study hints at the potential of sleep pills to slow or stop Alzheimer's disease progression

Sleep disturbances can be an early sign of Alzheimer's disease. Many people eventually diagnosed with Alzheimer's start experiencing difficulty falling and staying asleep years before cognitive problems such as memory loss and confusion emerge.

20 Apr 2023

Antibody combination strongly protects high-risk people with early COVID-19 symptoms, trial shows

A treatment combining two antibodies against the coronavirus SARS-CoV-2 strongly protected high-risk people with early COVID-19 symptoms from hospitalization and death in an international Phase 2/3 clinical trial conducted in the first half of 2021 and co-led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.

20 Apr 2023

Teriflunomide may delay first symptoms of multiple sclerosis, study shows

A drug called teriflunomide may delay first symptoms for people whose magnetic resonance imaging (MRI) scans show signs of multiple sclerosis (MS) even though they do not yet have symptoms of the disease.

20 Apr 2023

New drug may offer relief for people with difficult-to-treat migraine

The drug atogepant may help prevent migraines for people who have had no success with other preventive drugs, according to a preliminary study released April 20, 2023, which will be presented at the American Academy of Neurology's 75th Annual Meeting being held in person in Boston and live online from April 22-27, 2023.

20 Apr 2023

Combination of fluvoxamine and inhaled budesonide reduces severe COVID-19 in high-risk outpatients

Research reports the results of a randomized, placebo-controlled trial that investigated the effects of combining fluvoxamine and inhaled budesonide for preventing disease progression in high-risk outpatients with COVID-19. The study found that the combination treatment reduced the incidence of severe disease requiring advanced care.

20 Apr 2023

Early use of dexamethasone associated with reduced mortality in hospitalized COVID-19 requiring breathing support

In a recent study published in the journal JAMA Network Open, researchers examined the clinical use of dexamethasone for hospitalized patients with coronavirus disease 2019 (COVID-19) respiratory illness and explored the heterogeneity of treatment outcomes across different subgroups.

19 Apr 2023

Surgery may be better option to relieve leg pain and disability in some people with sciatica

Surgery to relieve leg pain and disability in some people with sciatica may be better than other non-surgical treatments, but the benefits are short-lived, lasting only up to 12 months, finds an analysis of the latest evidence published by The BMJ today.

19 Apr 2023

Assessing the efficacy, safety and tolerability of AXA1125 in long COVID patients

Researchers evaluated the effectiveness of endogenous metabolic modulator, AXA1125.

19 Apr 2023

Combination treatment could improve stem cell transplantation process for multiple myeloma patients

The standard treatment for patients with multiple myeloma often includes stem cell transplantation in which the patient's own stem cells are harvested and stored while the patient receives intensive chemotherapy to kill the cancer.

17 Apr 2023

Pre- and post-surgical immunotherapy-based treatment significantly improved lung cancer outcomes

A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete response (pCR) rates compared to chemotherapy alone for patients with operable non-small cell lung cancer (NSCLC), according to Phase III trial results presented today by researchers from The University of Texas MD Anderson Cancer Center at the American Association for Cancer Research (AACR) Annual Meeting 2023.

17 Apr 2023

Placebo in addition to methadone shown to be feasible treatment for opioid use disorder

There were more than 100,000 reported deaths from opioid overdoses in 2021, according to the Centers for Disease Control and Prevention.

12 Apr 2023

VUMC-led trial demonstrates the inefficacy of two investigational drugs for treating severe COVID-19

Despite the success of vaccines for preventing COVID-19, and of drugs for treating the disease, outcomes for severely ill patients admitted to the hospital remains poor.

11 Apr 2023

Daily statin medication could improve cardiovascular outcomes in people with HIV

A National Institutes of Health clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this population.

11 Apr 2023

The Parkinson's Pandemic: from the importance of early diagnosis to digital solutions

News Medical spoke to Michele Hu, Consultant Neurologist at Oxford University Hospitals and Professor of Clinical Neuroscience at the Nuffield Department of Clinical Neurosciences, University of Oxford, about prodromal Parkinson's and what the future looks like for this neurological disease.

11 Apr 2023

Age at menopause and hormone therapy use associated with increased risk of Alzheimer’s disease

Women are more likely than men to develop Alzheimer's disease (AD), with women making up two-thirds of the population living with AD.

3 Apr 2023

Vedolizumab found to be effective for the treatment of chronic pouchitis after colectomy

12% of people with ulcerative colitis need surgery to have their colon removed (colectomy). Most of those have an ileo-anal pouch surgically constructed from their small bowel, which means that they don't have to live with a stoma bag.

31 Mar 2023

An apple a day keeps the doctor away: polyphenol-enriched apples alter immune cell gene expression and fecal microbiota composition

Researchers compared the effects of consuming red-fleshed apples and white-fleshed among healthy adults.

29 Mar 2023

Placebo News and Research

What are the frequency and risk of adverse events developing in patients with epilepsy who are using CBD?

An exploration of the pathophysiological factors and abnormalities of coagulation of long-COVID

Review confirms that cranberry products help prevent urinary tract infections

Study hints at the potential of sleep pills to slow or stop Alzheimer's disease progression

Antibody combination strongly protects high-risk people with early COVID-19 symptoms, trial shows

Teriflunomide may delay first symptoms of multiple sclerosis, study shows

New drug may offer relief for people with difficult-to-treat migraine

Combination of fluvoxamine and inhaled budesonide reduces severe COVID-19 in high-risk outpatients

Early use of dexamethasone associated with reduced mortality in hospitalized COVID-19 requiring breathing support

Surgery may be better option to relieve leg pain and disability in some people with sciatica

Assessing the efficacy, safety and tolerability of AXA1125 in long COVID patients

Combination treatment could improve stem cell transplantation process for multiple myeloma patients

Pre- and post-surgical immunotherapy-based treatment significantly improved lung cancer outcomes

Placebo in addition to methadone shown to be feasible treatment for opioid use disorder

VUMC-led trial demonstrates the inefficacy of two investigational drugs for treating severe COVID-19

Daily statin medication could improve cardiovascular outcomes in people with HIV

The Parkinson's Pandemic: from the importance of early diagnosis to digital solutions

Age at menopause and hormone therapy use associated with increased risk of Alzheimer’s disease

Vedolizumab found to be effective for the treatment of chronic pouchitis after colectomy

An apple a day keeps the doctor away: polyphenol-enriched apples alter immune cell gene expression and fecal microbiota composition

Industry Focus eBook - Cell biology (5th edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News